Clinical Trials Directory

Trials / Completed

CompletedNCT03766035

Cholangioscopy in Primary Sclerosing Cholangitis (PSC)

Status
Completed
Phase
Study type
Observational
Enrollment
43 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard endoscopic retrograde cholangiopancreatography (ERCP) with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).

Detailed description

The primary objective of this study is to demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard ERCP with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).

Conditions

Interventions

TypeNameDescription
DEVICESpyGlass DS I - IIThe SpyScope™ DS Access and Delivery Catheter (SpyScope™ DS Catheter) is a sterile, single-use endoscope that enables access and delivery of accessories to targeted pancreaticobiliary anatomy and displays live video when connected to a Spy Glass DS Digital Controller.

Timeline

Start date
2018-12-06
Primary completion
2022-12-12
Completion
2022-12-12
First posted
2018-12-05
Last updated
2023-01-25

Locations

6 sites across 4 countries: United States, Canada, Netherlands, Norway

Regulatory

Source: ClinicalTrials.gov record NCT03766035. Inclusion in this directory is not an endorsement.